Clincosm LogoSign in Get a demo

head and neck squamous cell carcinoma

Showing 26 - 50 of 321
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

Not yet recruiting
  • Cervical Cancer
  • +5 more
  • HRYZ-T101 Injection
  • Fludarabine + Cyclophosphamide
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 17, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Cancer
  • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun yat-sun memorial hospital
Jul 10, 2023

Ascertaining Radiologic Prognostic Importance of Extranodal

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Extranodal extension
  • Omaha, Nebraska
  • +11 more
Jul 11, 2023

Head and Neck Squamous Cell Carcinoma Trial (MRI)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • MRI
  • (no location specified)
Jun 21, 2023

Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Streptococcus salivarius K12, Streptococcus salivarius K12 simulants)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Streptococcus salivarius K12
  • Streptococcus salivarius K12 simulants
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jun 14, 2023

Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

Not yet recruiting
  • Metastatic Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 19, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • (no location specified)
Jun 9, 2023

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Head and Neck Squamous Cell Carcinoma Trial in New York (HRQOL instruments, LENT SOMA instrument)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • HRQOL instruments
  • LENT SOMA instrument
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
May 25, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +18 more
  • Basking Ridge, New Jersey
  • +6 more
May 18, 2023

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • dose-reduced radiotherapy
  • Zhuhai, Guangdong, China
    Fifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • inulin
  • +2 more
  • Candiolo, Turin, Italy
    Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Apr 7, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial (ENDURE)

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • ENDURE
  • (no location specified)
Apr 2, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

Not yet recruiting
  • Cervical Cancer
  • +6 more
  • Fludarabine + Cyclophosphamide
  • HRYZ-T101 TCR-T Cell
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

Head and Neck Squamous Cell Carcinoma Trial in Spain (Dostarlimab, Niraparib, cisplatin plus radiotherapy)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Badalona, Cataluña, Spain
  • +4 more
Mar 13, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

3D Specimen Maps for RT Planning

Recruiting
  • Head and Neck Cancer
  • +2 more
    • Nashville, Tennessee
      Vanderbilt Medical Center
    Feb 23, 2023

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Feb 11, 2023